Daniel Brungs
Impact in
- Oncology top 10%
- Cancer Cells and Metastasis
- Cancer Immunotherapy and Biomarkers
- Colorectal Cancer Treatments and Studies
- Cancer Research top 10%
- Cancer Genomics and Diagnostics
Papers in
- Oncology 30
- Cancer Immunotherapy and Biomarkers 10
- Cancer Cells and Metastasis 8
- CAR-T cell therapy research 7
- Immunology 11
- Immunotherapy and Immune Responses 7
- Co-authors
- Morteza Aghmesheh (20 shared papers)Therese Maria Becker (13 shared papers)Martin Carolan (9 shared papers)Marie Ranson (12 shared papers)Kara L. Vine (8 shared papers)Paul de Souza (9 shared papers)Richard J. Epstein (2 shared papers)Joseph William Po (5 shared papers)
- Journals
- Cancers (4 papers)Annals of Oncology (3 papers)International Journal of Molecular Sciences (2 papers)Journal of Clinical Oncology (2 papers)PLoS ONE (2 papers)
- Partner nations
- AustraliaUnited StatesFrance
In The Last Decade
Daniel Brungs
46 papers receiving 954 citations
Daniel Brungs's Hit Papers
Peers
Comparison fields: 5 of 79
- Oncology 378
- Cancer Research 179
- Pulmonary and Respiratory Medicine 271
- Genetics 49
- Biotechnology 35
Countries citing papers authored by Daniel Brungs
This map shows the geographic impact of Daniel Brungs's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Brungs with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Brungs more than expected).
Fields of papers citing papers by Daniel Brungs
This network shows the impact of papers produced by Daniel Brungs. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Brungs. The network helps show where Daniel Brungs may publish in the future.
Co-authors
The 25 scholars most cited alongside Daniel Brungs, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 48 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Testosterone suppression plus enzalutamide versus testosterone suppression plus standard antiandrogen therapy for metastatic hormone-sensitive prostate cancer (ENZAMET): an international, open-label, randomised, phase 3 trial Hit paper breakdown → | 2023 | 134 |
| 2 | Datopotamab Deruxtecan Versus Docetaxel for Previously Treated Advanced or Metastatic Non–Small Cell Lung Cancer: The Randomized, Open-Label Phase III TROPION-Lung01 Study Hit paper breakdown → | 2024 | 129 |
| 3 | 2015 | 111 | |
| 4 | 2021 | 50 | |
| 5 | 2017 | 43 | |
| 6 | 2020 | 39 | |
| 7 | 2013 | 38 | |
| 8 | 2020 | 37 | |
| 9 | 2017 | 37 | |
| 10 | 2023 | 34 | |
| 11 | 2014 | 25 | |
| 12 | 2025 | 23 | |
| 13 | 2020 | 23 | |
| 14 | 2018 | 22 | |
| 15 | 2020 | 21 | |
| 16 | 2020 | 20 | |
| 17 | 2018 | 20 | |
| 18 | 2018 | 19 | |
| 19 | 2019 | 18 | |
| 20 | 2025 | 15 |
About Daniel Brungs
Daniel Brungs is a scholar working on Oncology, Immunology, Cancer Research, Pulmonary and Respiratory Medicine and Biotechnology, having authored 48 papers that have together received 963 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (10 papers), Cancer Cells and Metastasis (8 papers), CAR-T cell therapy research (7 papers), Immunotherapy and Immune Responses (7 papers), Nonmelanoma Skin Cancer Studies (6 papers), Cancer Genomics and Diagnostics (4 papers), Cancer Research and Treatments (4 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (3 papers). The work is most often cited by research in Oncology (378 citations), Cancer Research (179 citations), Pulmonary and Respiratory Medicine (271 citations), Genetics (49 citations) and Biotechnology (35 citations). Daniel Brungs has collaborated with scholars based in Australia, United States and France. Frequent co-authors include Morteza Aghmesheh, Therese Maria Becker, Martin Carolan, Marie Ranson, Kara L. Vine, Paul de Souza, Richard J. Epstein, Joseph William Po, Gurdeep Parmar and Nick Pavlakis. Their work appears in journals such as Cancers, Annals of Oncology, International Journal of Molecular Sciences, Journal of Clinical Oncology and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.